BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28612546)

  • 21. Whole-body biodistribution of 3'-deoxy-3'-[(18) f]fluorothymidine ((18) FLT) in healthy adult cats.
    Rowe JA; Morandi F; Wall JS; Akula M; Kennel SJ; Osborne D; Martin EB; Galyon GD; Long MJ; Stuckey AC; LeBlanc AK
    Vet Radiol Ultrasound; 2013; 54(3):299-306. PubMed ID: 23464567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.
    Eckel F; Herrmann K; Schmidt S; Hillerer C; Wieder HA; Krause BJ; Schuster T; Langer R; Wester HJ; Schmid RM; Schwaiger M; Buck AK
    J Nucl Med; 2009 Sep; 50(9):1441-7. PubMed ID: 19690030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice.
    Tseng JR; Dandekar M; Subbarayan M; Cheng Z; Park JM; Louie S; Gambhir SS
    J Nucl Med; 2005 Nov; 46(11):1851-7. PubMed ID: 16269599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new precursor for the radiosynthesis of [18F]FLT.
    Martin SJ; Eisenbarth JA; Wagner-Utermann U; Mier W; Henze M; Pritzkow H; Haberkorn U; Eisenhut M
    Nucl Med Biol; 2002 Feb; 29(2):263-73. PubMed ID: 11823132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3'-Sulfonylesters of 2,5'-anhydro-1-(2-deoxy-beta-d-threo-pentofuranosyl)thymine as precursors for the synthesis of [(18)F]FLT: syntheses and radiofluorination trials.
    Windhorst AD; Klein PJ; Eisenbarth J; Oeser T; Kruijer PS; Eisenhut M
    Nucl Med Biol; 2008 May; 35(4):413-23. PubMed ID: 18482678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3'-Deoxy-3'-18F-fluorothymidine as a proliferation imaging tracer for diagnosis of lung tumors: comparison with 2-deoxy-2-18f-fluoro-D-glucose.
    Yamamoto Y; Nishiyama Y; Ishikawa S; Gotoh M; Bandoh S; Kanaji N; Asakura M; Ohkawa M
    J Comput Assist Tomogr; 2008; 32(3):432-7. PubMed ID: 18520552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of
    Vercellino L; Ouvrier MJ; Barré E; Cassinat B; de Beco V; Dosquet C; Chevret S; Meignin V; Chomienne C; Toubert ME; Merlet P; Kiladjian JJ
    J Nucl Med; 2017 Oct; 58(10):1603-1608. PubMed ID: 28360204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of [18F]-fluoro-L-thymidine ([18F]-FLT) for positron emission tomography imaging.
    Bourgeois M; Mougin-Degraef M; Leost F; Cherel M; Gestin JF; Le Bars D; Barbet J; Faivre-Chauvet A
    J Pharm Biomed Anal; 2007 Sep; 45(1):154-157. PubMed ID: 17566690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
    Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
    Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review on [(18)F]FLT-PET uptake as a measure of treatment response in cancer patients.
    Bollineni VR; Kramer GM; Jansma EP; Liu Y; Oyen WJ
    Eur J Cancer; 2016 Mar; 55():81-97. PubMed ID: 26820682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
    Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
    J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using
    Xu HL; Li M; Zhang RJ; Jiang HJ; Zhang MY; Li X; Wang YQ; Pan WB
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):140-148. PubMed ID: 29571649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer.
    Leimgruber A; Möller A; Everitt SJ; Chabrot M; Ball DL; Solomon B; MacManus M; Hicks RJ
    J Nucl Med; 2014 Jul; 55(7):1075-80. PubMed ID: 24868108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
    Zannetti A; Iommelli F; Speranza A; Salvatore M; Del Vecchio S
    J Nucl Med; 2012 Mar; 53(3):443-50. PubMed ID: 22331221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer.
    Francis DL; Visvikis D; Costa DC; Arulampalam TH; Townsend C; Luthra SK; Taylor I; Ell PJ
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):988-94. PubMed ID: 12739071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxygen breathing affects 3'-deoxy-3'-18F-fluorothymidine uptake in mouse models of arthritis and cancer.
    Fuchs K; Kukuk D; Reischl G; Föller M; Eichner M; Reutershan J; Lang F; Röcken M; Pichler BJ; Kneilling M
    J Nucl Med; 2012 May; 53(5):823-30. PubMed ID: 22492733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
    van Waarde A; Cobben DC; Suurmeijer AJ; Maas B; Vaalburg W; de Vries EF; Jager PL; Hoekstra HJ; Elsinga PH
    J Nucl Med; 2004 Apr; 45(4):695-700. PubMed ID: 15073267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging of thymidine kinase 1 activity after 5-fluorouracil treatment in a mouse tumor model.
    Hong IK; Kim SY; Chung JH; Lee SJ; Oh SJ; Lee SJ; Oh J; Ryu JS; Kim TW; Kim DY; Moon DH
    Anticancer Res; 2014 Feb; 34(2):759-66. PubMed ID: 24511010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.